[1] |
Bonora E, Kiechl S, Willeit J, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes, 2004; 53, 1782-9. doi: 10.2337/diabetes.53.7.1782 |
[2] |
Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet, 2005; 365, 610-2. doi: 10.1016/S0140-6736(05)17912-4 |
[3] |
Matsumoto K, Fujita N, Ozaki M, et al. Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract, 2006; 74, 316-21. doi: 10.1016/j.diabres.2006.04.014 |
[4] |
Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes, 2006; 55, 1133-40. doi: 10.2337/diabetes.55.04.06.db05-1076 |
[5] |
Dehghan A, van Hoek M, Sijbrands EJ, et al. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care, 2007; 30, 2695-9. http://cn.bing.com/academic/profile?id=ebdc0d99b44d2474cc2fa3d9cb3a3d53&encoded=0&v=paper_preview&mkt=zh-cn |
[6] |
Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA, 2004; 291, 1978-86. doi: 10.1001/jama.291.16.1978 |
[7] |
Chu KY, Leung PS. Angiotensin Ⅱ in type 2 diabetes mellitus. Curr Protein Pept Sci, 2009; 10, 75-84. doi: 10.2174/138920309787315176 |
[8] |
Matsumoto K, Sera Y, Abe Y, et al. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis, 2003; 169, 317-21. doi: 10.1016/S0021-9150(03)00198-9 |
[9] |
Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest, 2008; 38, 502-9. doi: 10.1111/j.1365-2362.2008.01962.x |
[10] |
Scheen AJ, Esser N, Paquot N. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control. Diabetes Metab, 2015; 41, 183-94. doi: 10.1016/j.diabet.2015.02.003 |